FGFR2 and neuroblastoma: While the role of FGFR2 in neuroblastoma drug resistance and pathogenesis remains to be clarified, our analysis, combined with its function downstream of MYCN, suggests FGFR2 may be an effective target for highly potent small molecule inhibitors.